N1-(6-fluoropyridin-3-yl)-N2-(1-(2-(5-guanidinopentanamido)ethyl)-1-azaspiro[5.5]undecan-4-yl)oxalamide tris(2,2,2-trifluoroacetate)

ID: ALA5177492

Chembl Id: CHEMBL5177492

PubChem CID: 168272612

Max Phase: Preclinical

Molecular Formula: C31H42F10N8O9

Molecular Weight: 518.64

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCCCCC(=O)NCCN1CCC(NC(=O)C(=O)Nc2ccc(F)nc2)CC12CCCCC2.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C25H39FN8O3.3C2HF3O2/c26-20-8-7-19(17-31-20)33-23(37)22(36)32-18-9-14-34(25(16-18)10-3-1-4-11-25)15-13-29-21(35)6-2-5-12-30-24(27)28;3*3-2(4,5)1(6)7/h7-8,17-18H,1-6,9-16H2,(H,29,35)(H,32,36)(H,33,37)(H4,27,28,30);3*(H,6,7)

Standard InChI Key:  JQLYVAKBEITRBM-UHFFFAOYSA-N

Associated Targets(Human)

TZM (838 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

env Envelope glycoprotein gp160 (755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 518.64Molecular Weight (Monoisotopic): 518.3129AlogP: 1.21#Rotatable Bonds: 10
Polar Surface Area: 165.33Molecular Species: BASEHBA: 6HBD: 6
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.25CX Basic pKa: 12.25CX LogP: -0.25CX LogD: -3.59
Aromatic Rings: 1Heavy Atoms: 37QED Weighted: 0.09Np Likeness Score: -0.97

References

1. Tsuji K, Kobayakawa T, Konno K, Masuda A, Takahashi K, Ohashi N, Yoshimura K, Kuwata T, Matsushita S, Harada S, Tamamura H..  (2022)  Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitors.,  56  [PMID:35063895] [10.1016/j.bmc.2022.116616]

Source